Micro-Sample Viscometer Chosen in FDA Nanotechnology Toxicology Study

The FDA’s National Center for Toxicological Research (NCTR) has purchased a micro-sample viscometer, VISCOLab 5000, to better characterize and detect nanoscale materials.  The agency’s research involves the manipulation of biological buffers in saline solutions with tissue culture media ranging from .001 to .1 micrometer in size, and less than 1 ml of serum for total characterization.

The Cambridge viscometer was selected for its small—75 micro-liters—sample requirement, accuracy and repeatability.

With the increased use of products based on nanotechnology in food and drugs, as well as medical devices, biologics and food, the NCTR is conducting research and developing appropriate tools and methods to promote regulatory processes and public health decisions. This involves developing techniques to detect nanoscale materials in toxicological studies, as well as in biological samples. Material samples available for toxicology analysis are limited, making the micro-sample viscometer an ideal solution as it requires very small sample size. 

Cambridge Regional Sales Manager William Small explains, “We were awarded the government bid for the VISCOlab 5000 because the system meets the application requirement for a very small amount of sample. It is a micro-sample viscometer that is very easy to use and produces accurate results in a timely manner.”

Comments

Popular posts from this blog

What is Class I Division 2?

FUSE SIZING CONSIDERATIONS FOR HIGHER EFFICIENCY MOTORS

7/8 16UN Connectors that Provide 600 Volts and 15 Amps